Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FHNX1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,584
Award facts
- Contract value 100% obligated
- $16,584.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,584.13 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The contract, issued without set-aside designation, is scheduled for completion by February 26, 2026, and represents performance under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency. No subcontractors were identified in the award documentation.
This delivery order falls under DMS Pharmaceutical Group's role as a regional prime vendor contractor within the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply pharmaceutical products and medical consumables to military healthcare facilities worldwide. The parent IDC, valued at $499,999,999 and awarded in November 2025, authorizes the Defense Logistics Agency to issue firm fixed-price delivery orders for branded and generic pharmaceuticals, biologics, and medical supplies. Stelara, an immunosuppressant biologic agent, represents one of the specialized pharmaceutical products DMS Pharmaceutical Group is positioned to deliver under this strategic prime vendor arrangement supporting Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FHNX1?
SPE2DR26FHNX1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FHNX1 worth?
The government has obligated $16,584 on SPE2DR26FHNX1.
Is contract SPE2DR26FHNX1 an order under another contract?
Yes. SPE2DR26FHNX1 is a delivery order under SPE2DR25D9231, an indefinite delivery contract.
Was contract SPE2DR26FHNX1 competed?
The extent of competition for SPE2DR26FHNX1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award